This page indicated the Clinical Implications across these treatments:
Ellex is the manufacturer of the Tango Reflex and Tango for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma. Tango Reflex and Tango have been approved for the indication of Selective Laser Trabeculoplasty (SLT) whereby they may potentially improve patient IOP. Ellex does not accept any responsibility for use of the systems outside of this indication.
Ellex is the manufacturer of Reflex Technology for use in the treatment of symptomatic floater patients. It has been approved for the indication of Posterior Membranectomy whereby it offers the potential to improve the patient’s perception of visual functionality. Ellex does not accept any responsibility for use of the system outside of these indications. The material presented herein may include the views or recommendations of third parties and does not necessarily reflect the views of Ellex Medical Pty Ltd.
Ultra Q Reflex™ has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) (510k) Market release for the treatment Posterior Membranectomy, Capsulotomy and Laser Iridotomy.
Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.
The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.